Generic drugmakers denied bid for bifurcated trial in Humana's US price-fixing case
( August 28, 2026, 19:26 GMT | Official Statement) -- MLex Summary: Major US generic drug manufacturers failed to convince a Pennsylvania federal judge overseeing a bellwether price-fixing trial over claims from Humana to bifurcate the proceedings into liability and damages phases. In an order filed in the Eastern District of Pennsylvania, US District Judge Cynthia Rufe said she disagreed with the defendants' arguments that bifurcation would simplify the scope of the trial, enhance the jurors' grasp of each phase and conserve judicial resources.See attached document....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.